The Trend of Serum Creatinine Does Not Predict Follow-Up Biopsy Findings Among Kidney Transplant Recipients With Antibody-Mediated Rejection

The Trend of Serum Creatinine Does Not Predict Follow-Up Biopsy Findings Among Kidney Transplant Recipients With Antibody-Mediated Rejection

Background. Traditionally, antibody-mediated rejection (AMR) has been suspected mainly by a rise in serum creatinine (Scr) and confirmed by allograft biopsy. There is limited literature describing the trend of Scr after treatment, and how that trend might differ between patients with histological re...

Full description

Bibliographic Details
Main Authors: Sandesh Parajuli, MD, Weixiong Zhong, MD, Monika Pantha, BS, Megan Sokup, PA, Fahad Aziz, MD, Neetika Garg, MD, Maha Mohamed, MD, Didier Mandelbrot, MD
Format: Article
Language:English
Published: Wolters Kluwer 2023-06-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001489

Internet

http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001489

Similar Items